Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

SeaStar Medical Holding Corp logo

SeaStar Medical Holding Corp

US$3.71

US$6.9m

3.34%

104.97%

Dashboard Funda..tals Deep..lue Prediction Screener Map

SeaStar Medical Holding Corp Overview

Industry: Healthcare Equipment & Supplies

Sector: Healthcare

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.

SeaStar Medical Holding Corp is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review SeaStar Medical Holding Corp in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



SeaStar Medical Holding Corp Competitors

SeaStar Medical Holding Corp operates in the Healthcare Equipment & Supplies industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

SeaStar Medical Holding Corp

US$3.71

US$6.9m

3.34%

104.97%